APA

Raaijmakers M. H. G. P., de Grouw E. P. L. M., van der Reijden B. A., de Witte T. J. M., Jansen J. H. & Raymakers R. A. P. (20071109). ABCB1 modulation does not circumvent drug extrusion from primitive leukemic progenitor cells and may preferentially target residual normal cells in acute myelogenous leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Raaijmakers Marc H G P, de Grouw Elke P L M, van der Reijden Bert A, de Witte Theo J M, Jansen Joop H and Raymakers Reinier A P. 20071109. ABCB1 modulation does not circumvent drug extrusion from primitive leukemic progenitor cells and may preferentially target residual normal cells in acute myelogenous leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Raaijmakers M. H. G. P., de Grouw E. P. L. M., van der Reijden B. A., de Witte T. J. M., Jansen J. H. and Raymakers R. A. P. (20071109). ABCB1 modulation does not circumvent drug extrusion from primitive leukemic progenitor cells and may preferentially target residual normal cells in acute myelogenous leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Raaijmakers Marc H G P, de Grouw Elke P L M, van der Reijden Bert A, de Witte Theo J M, Jansen Joop H and Raymakers Reinier A P. ABCB1 modulation does not circumvent drug extrusion from primitive leukemic progenitor cells and may preferentially target residual normal cells in acute myelogenous leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20071109.